Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition resulting from build-up of fluid in the air sacs (alveoli) following an insult on the lung. This fluid prevents enough oxygen from passing into the bloodstream.
ARDS remains a substantial cause of morbidity and mortality in intensive care units, yet no specific pharmacotherapy has proven useful in reducing the duration of mechanical ventilation or improving survival. One factor that might hamper the development of treatment for acute respiratory distress syndrome is the heterogeneous nature of the population who present with the syndrome.
More details are in the attached flier.